Logistics giant DHL says that the healthcare industry is currently under siege, buffeted by a host of new market forces which are changing the business paradigm.
‘Going Direct: Bold strategy for healthcare supply chains’ is the group's latest whitepaper which looks at how new market dynamics are having a direct impact on the performance of medical manufacturers. Cost pressures; wholesaler, manufacturer and pharmacy consolidation; along with new regulations, are forcing life science manufacturers to look at different opportunities to reduce costs and improve margins.